33077-70-2

Basic information

• Product Name: p-hydroxyphenyl 2-pyridyl ketone
• Synonyms: p-hydroxyphenyl 2-pyridyl ketone
• CAS NO: 33077-70-2
• Molecular Formula: C₁₂H₉NO₂
• Molecular Weight: 199.20536
• EINECS: 251-368-6
• Mol File: 33077-70-2.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 336.72°C (rough estimate)
• Flash Point: 192.5°C
• Appearance: /
• Density: 1.1919 (rough estimate)
• Vapor Pressure: 8.5E-07mmHg at 25°C
• Refractive Index: 1.5880 (estimate)
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: p-hydroxyphenyl 2-pyridyl ketone(CAS DataBase Reference)
• NIST Chemistry Reference: p-hydroxyphenyl 2-pyridyl ketone(33077-70-2)
• EPA Substance Registry System: p-hydroxyphenyl 2-pyridyl ketone(33077-70-2)

Safety Data

• Hazardous Substances Data: 33077-70-2(Hazardous Substances Data)

Usage

InChI:InChI=1/C12H9NO2/c14-10-6-4-9(5-7-10)12(15)11-3-1-2-8-13-11/h1-8,14H

Upstream product

• 29745-44-6 pyridine-2-carbonyl chloride 
• 98-98-6 2-Picolinic acid 
• 5029-67-4 2-iodopyridine 
• 99-96-7 4-hydroxy-benzoic acid 
• 6305-18-6 2-(4-methoxybenzoyl)pyridine 
• 26838-86-8 pyridine-2-carboxylic acid phenyl ester 

Downstream Products

• 1231922-04-5 (4-(3-chloropyrazin-2-yloxy)phenyl)(pyridin-2-yl)methanone 
• 1231923-83-3 Pyridin-2-yl(4-(3-(tetrahydro-2H-pyran-4-yl)pyridin-2-yloxy)phenyl)methanone 
• 21464-43-7 4-(5,5-diphenyl-2-piperidin-2-yl-[1,3]dioxan-2-yl)-phenol 
• 603-50-9 bisacodyl 
• 603-41-8 4,4'-(2-pyridylmethylene)diphenol 
• 21464-88-0 4-(5,5-diphenyl-2-pyridin-2-yl-[1,3]dioxan-2-yl)-phenol 

Relevant articles and documents

The light-emitting compound and use this light-emitting compound of the organic light emitting diode device

An embodiment of the present invention provides an emitting compound of following formula: wherein “A” is represented by and “B” is represented by

AMINOPYRIDINE AND CARBOXYPYRIDINE COMPOUNDS AS PHOSPHODIESTERASE 10 INHIBITORS

Pyridine and pyrimidine compounds: or a pharmaceutically acceptable salt thereof, wherein m, n, R1, R2, R3, R4, R5, R6, R7, X1, X2, X3, X4, X5, X6, X7, X8, and Y are as defined in the specification; or a pharmaceutically acceptable salt thereof, wherein ring A, m, n, y, R2, R3, R4, R5, R6, R7, R8, R9, X1, X2, and ring A are as defined in the specification; and or a pharmaceutically acceptable salt thereof, wherein m, n, y, R2, R3, R4, R5, R6, R7, R9, X1, X2, and ring A are as defined in the specification; compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.